Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (26)
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 • 6,878 citations
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 • 2,711 citations
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
2000 • 2,700 citations
Clinical translation of angiogenesis inhibitors
2002 • 1,518 citations
Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes
1985 • 1,292 citations
THE EPHRINS AND EPH RECEPTORS IN NEURAL DEVELOPMENT
1998 • 1,082 citations
Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185
1986 • 1,020 citations
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
1999 • 990 citations
The binding site for C1q on IgG
1988 • 556 citations
Regulated Cleavage of a Contact-Mediated Axon Repellent
2000 • 522 citations
Eph receptors and ephrins: effectors of morphogenesis
1999 • 445 citations
A model of angiogenesis in the mouse cornea.
1996 • 411 citations
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
2000 • 379 citations
Role of B61, the Ligand for the Eck Receptor Tyrosine Kinase, in TNF-α-Induced Angiogenesis
1995 • 368 citations
The ephrins and Eph receptors in angiogenesis
2002 • 336 citations
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
2002 • 317 citations
Eph receptors and ephrin ligands: embryogenesis to tumorigenesis
2000 • 297 citations
Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.
1999 • 292 citations
Localization of the binding site for the human high-affinity Fc receptor on IgG
1988 • 287 citations
Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.
2001 • 259 citations
Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models
1996 • 246 citations
Angiogenesis modulation in cancer research: novel clinical approaches
2002 • 181 citations
Ephrins and their receptors: a repulsive topic?
1997 • 154 citations
Vascular patterning by Eph receptor tyrosine kinases and ephrins
2002 • 111 citations
Characterization of B61, the Ligand for the Eck Receptor Protein-Tyrosine Kinase
1995 • 65 citations
Molecular definition of interaction sites on human IgG for Fc receptors (huFcγR)
1990 • 61 citations